High NT‑proBNP indicates increased cardiac wall stress and is commonly a marker of heart failure or worsening cardiac function. Elevated levels can reflect acute or chronic heart failure, myocardial ischemia, valvular disease, arrhythmias, pulmonary embolism, or reduced kidney clearance. Higher values correlate with greater severity and worse prognosis. Interpretation requires clinical correlation and further testing by a healthcare professional.

BNP helps stratify heart failure probability: BNP <100 pg/mL makes heart failure unlikely; BNP 100–400 pg/mL is indeterminate and warrants further testing (echocardiography, clinical assessment); BNP >400 pg/mL strongly suggests heart failure. For NT‑proBNP, lower cutoffs apply (e.g., <125 pg/mL generally excludes chronic heart failure; higher age-dependent thresholds indicate probable heart failure).

Both BNP and NT‑proBNP diagnose and monitor heart failure, but NT‑proBNP is often preferred because it’s more stable in blood, has a longer half‑life, and provides robust diagnostic and prognostic information. BNP can be useful in acute settings and for therapy monitoring. Choice depends on assay availability, clinical context, renal function, and patient factors like obesity, which can alter levels.

Treating elevated NT‑proBNP focuses on diagnosing and managing underlying heart failure or cardiac stress. Optimize guideline-directed therapy—diuretics for congestion, ACE inhibitor/ARB/ARNI, beta‑blocker, mineralocorticoid antagonist—and address ischemia, arrhythmia, hypertension, anemia, and renal issues. Lifestyle measures (salt restriction, fluid management, weight monitoring) and timely cardiology follow-up guide adjustments, device or advanced interventions if needed. Consult your clinician.

High NT‑proBNP indicates cardiac wall stress and is strongly associated with heart failure and reduced cardiac function. Elevated levels predict higher risk of hospitalization, arrhythmias, and cardiovascular death, and signal fluid overload or worsening heart disease. Levels can be affected by age and kidney dysfunction. Persistent elevation warrants prompt cardiac assessment and targeted treatment to reduce morbidity and mortality.

BNP (B‑type natriuretic peptide) is generally considered normal if <100 pg/mL, though levels rise with age, renal disease and other conditions. For the related NT‑proBNP test, age‑adjusted upper limits commonly used are: <50 years: 450 pg/mL; 50–75 years: 900 pg/mL; >75 years: 1,800 pg/mL. Interpret values with clinical context. Discuss abnormal results with a clinician.